一岁儿童患有结核性脑膜炎,其肝毒性由伊索尼亚齐德诱导:一个病例报告
Satoshi Okada1, Shinsuke Mizuno2, Nobuyuki Akutsu3
1Division of Pediatric Critical Care Medicine, Hyogo Prefectural Kobe Children's Hospital, Hyogo, JPN.
Cureus
|September 8, 2025
概括
在发达国家,结核性脑膜炎 (TBM) 诊断可能会延迟. 这一案例强调了linezolid和levofloxacin作为异化的安全替代品,可以在TBM治疗期间预防肝损伤.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 儿科 儿科 儿科
背景情况:
- 结核性脑膜炎 (TBM) 很少见,但在发达国家难以诊断.
- 药物诱导的肝毒性是TBM治疗中的一个重要问题.
- 需要替代性抗结核药物,具有良好的CSF透率和安全性.
研究的目的:
- 报告一个发达国家儿童的TBM病例.
- 以突出成功管理异化物诱导的肝毒性.
- 建议TBM的替代治疗选择.
主要方法:
- 一个儿科患者的病例报告,怀疑TBM.
- 诊断工作包括MRI和CSF分析.
- 用标准的抗结核药物,类固醇和阿司匹林进行治疗.
- 通过用linezolid和levofloxacin替换异化物来控制药物诱导的肝毒性.
主要成果:
- 通过临床,成像和微生物学发现证实了TBM的诊断.
- 患者患有异化物诱导的肝毒性.
- 用linezolid和levofloxacin替代治疗消除了肝毒性,没有任何不良事件.
- 用替代疗法成功治疗TBM.
结论:
- 发达国家的临床医生应在患有神经症状的儿童中保持对TBM的高度怀疑.
- 林尼佐利德和勒沃素是治疗TBM时异化的有效和安全替代品,可减轻肝毒性.
- 早期诊断和适当的管理对于TBM的良好结果至关重要.
相关概念视频
Pulmonary Tuberculosis V
543
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
543
Pulmonary Tuberculosis I
846
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
846
Pulmonary Tuberculosis IV
480
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
480
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis III
946
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
946
Pharmacokinetics in Pediatric Patients: Drug Metabolism
195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195


